Hong Lab
Welcome to the Hong Lab
Decoding the molecular mechanisms of PAH to develop targeted therapies.
We are a research group at UCLA dedicated to uncovering the molecular mechanisms of pulmonary arterial hypertension (PAH) and related pulmonary vascular diseases. By integrating experimental and multiomics approaches, we aim to identify disease-driving pathways and develop targeted therapies to improve patient outcomes.
In the News
UCLA faculty honored by the American Society for Clinical Investigation
February 24, 2025
Four UCLA Health faculty have been elected to the American Society for Clinical Investigation (ASCI) while two others have earned Young Physician-Scientist Awards. All are members of the department of medicine at UCLA Health.
UCLA-led study unveils new insights and potential treatments for pulmonary hypertension
August 21, 2024
A new study from researchers with UCLA Health and collaborating organizations has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).
Q&A: Asporin linked to ‘more favorable disease profile’ in patients with PAH
October 02, 2024
In PAH lung samples, researchers observed elevated asporin levels and found a link between these levels and lower disease severity.
New insights and potential treatments for pulmonary hypertension
August 21, 2024
A new study has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).